COc1cc2c(cc1Oc1ccc(OC)c3c1CC1c4c(cc(OC)c(OC)c4-3)CCN1C)CC1c3c(cc(OC)c(OC)c3-2)CCN1C.Cl
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?